Incontinence Devices And Ostomy Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Desk Research

Desk research starts by mapping the demand pool and care pathways that drive product consumption, then checking where reliable public series exist. We relied on sources such as the World Health Organization for aging and disease burden context, the US Centers for Disease Control and Prevention for prevalence and risk factors, and OECD health statistics for long-term care and care-setting indicators. For procedure and condition context, sources such as the US National Library of Medicine and other peer-reviewed clinical journals helped validate typical ostomy use cases and replacement patterns.

On the supply and trade side, we cross-checked import-export signals, pricing references, and category descriptions using sources such as UN Comtrade, national customs portals where available, and medical device regulator websites that publish product classification and guidance (for example, the US FDA database pages). Company filings, annual reports, investor presentations, and trusted press were used to confirm portfolio mix and regional exposure. We also used paid subscriptions for company financials and for patent database lookups to validate innovation direction and product pipelines. The desk sources listed here are illustrative, and many other public sources were also used for data collection, cross-checks, and clarification.

Primary Interviews and Surveys

Primary interviews were used to convert broad prevalence and procedure signals into realistic product volumes, pricing bands, and channel splits, then stress test the key model assumptions. We spoke with a mix of manufacturers, distributors, clinicians involved in continence and ostomy care, and procurement and home-care stakeholders across APAC, EMEA, and the Americas to confirm replacement frequency, product mix, and the effect of reimbursement and care-setting shifts on ordering patterns.

Distribution of primary research fieldwork respondents

Sizing is built by reconstructing demand from the treated cohort and care setting, where prevalence, procedure volumes (for ostomy creation), and long-term care penetration are translated into product users and annual usage. We apply a top-down approach first, linking the prevalence-to-treated-cohort build-up to typical consumption rates for key incontinence and ostomy categories, then converting to value using average selling price bands by channel.

To keep the totals grounded, selective bottom-up approximations are used to validate and adjust the aggregated estimates. This includes supplier revenue checks, sampled price points across channels, and distributor feedback on category shares. Variables that typically matter in the model include the older adult population share, the long-term care and home-care mix, ostomy creation and reversal patterns, replacement frequency (pouching and skin barrier cycles), reimbursement breadth, and material cost movements that affect pricing. Forecasting is run using scenario analysis supported by short lists of drivers from experts, so the outlook reflects changes in demographics, care-setting shifts, and pricing progression rather than a single straight-line growth curve. When a country-level datapoint is missing, the gap is handled through proxy indicators, such as similar reimbursement structure and care-setting mix, and then rechecked with primary feedback before inclusion.

Validation is done by comparing independent checks across the model so the totals make sense from more than one angle, then following up where a mismatch appears. We review year-over-year movements against signals such as demographic changes, care-setting shifts, and trade and pricing markers, and then investigate outliers before final sign-off.

A second analyst review is applied to the assumptions, conversion steps, and currency treatment to reduce calculation errors and scope leakage. Reports are refreshed annually, with interim updates when material events change category demand or pricing. Before delivery, a final pass is completed so the published view reflects the latest available public data and the most recent expert feedback.

Published totals for this market can differ substantially even when they discuss similar products, largely because the inclusion rules and pricing averaging are not always the same. Variations usually come from whether adjacent wound and skin care items are counted, whether retail and reimbursement pricing are blended using the same method, and whether the latest care-setting mix has been captured.

The benchmark table shows a noticeable spread across 2024 values, and in Mordor Intelligence's model the total is built from incontinence and ostomy care product revenues only, with procedure and service spending kept outside the market and with usage frequency and channel-level pricing checked through primary inputs.

Benchmark comparison

Overall, the gap pattern mainly reflects scope edges and how volumes and prices are converted into revenue across channels. By keeping assumptions tied to repeatable variables such as treated users, replacement cycles, and channel level pricing bands, the estimate stays traceable and easier to replicate when new data points arrive.